Cite
HARVARD Citation
Devos, T. et al. (2022). Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis. Hematology. 27 (1), pp. 23-31. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Devos, T. et al. (2022). Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis. Hematology. 27 (1), pp. 23-31. [Online].